Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
NCT05164744
This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of cardiopulmonary symptoms, physical effort tolerance, and outcomes in COVID-19 survivors. If successful, the research will allow us to identify the causes of lasting cardiopulmonary symptoms and begin developing cardiac and lung directed therapies accordingly.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- COVID-19 Pneumonia
- COVID-19
- COVID-19 Respiratory Infection
- COVID-19 Acute Respiratory Distress Syndrome
- COVID-19 Lower Respiratory Infection
- COVID-19 Acute Bronchitis
- Coronavirus Disease 2019
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Weill Medical College of Cornell University
- Last updated on ClinicalTrials.gov
- January 22, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 3
- New York Presbyterian-Brooklyn Methodist Hospital · Brooklyn, NY
- New York Presbyterian Queens · New York, NY
- Weill Cornell Medicine/New-York Presbyterian Hospital · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.